Showing results (31-40 of 214) with videos related to
Sort By:
Pageof 22
AIDS Research and Human Retroviruses|July 10, 2004
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infectionPablo Tebas, Kevin Yarasheski, Keith Henry, et al.American Journal of Physiology. Endocrinology and Metabolism|July 3, 2003
Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemiaKevin E Yarasheski, Pablo Tebas, Sherry Claxton, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
A tale of 2 epidemics: the intersection between obesity and HIV infection in PhiladelphiaValerianna Amorosa, Marie Synnestvedt, Robert Gross, et al.AIDS (London, England)|October 27, 2010
Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretroviralsMark M Manak, Dmitry A Moshkoff, Lequan T Nguyen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2007
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384Michael P Dubé, Robert A Parker, Kathleen Mulligan, et al.The Journal of Infectious Diseases|November 26, 2002
Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failedMaria B Ristig, Jeffrey Crippin, Judith A Aberg, et al.AIDS Research and Human Retroviruses|August 9, 2002
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)Richard B Pollard, Camlin Tierney, Diane Havlir, et al.Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 29, 2003
Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS CareCalvin Cohen, Richard A Elion, Ian Frank, et al.IAPAC Monthly|June 24, 2005
Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS CareCarl J Fichtenbaum, Colleen M Hadigan, Donald P Kotler, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2017
Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Stephen Esker, et al.Pageof 22